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Thyroid Storm: Clinical 
Manifestation, Pathophysiology, 
and Treatment
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Abstract
Thyroid storm is a rare but life-threatening endocrine emergency. It is an acute 
exaggerated clinical manifestation of thyrotoxic state. The exact incidence is 
unknown. It occurs in 1–2% of patients admitted for thyrotoxicosis. It has a mortal-
ity of 10–20%. This chapter would help us to understand its clinical manifestations, 
pathophysiology, and effective treatment. Terminal learning objective would be to 
diagnose impending storm early and start prompt treatment in day-to-day practice. 
The chapter would cover pathophysiology including triggers, clinical features 
including various diagnostic criteria, diagnosis, and treatment of thyroid storm. 
Indications of surgical treatment in storm will be discussed.
Keywords: thyroid storm, endocrine emergency, thyroid crisis, thyrotoxic storm, 
thyrotoxic crisis
1. Introduction
Thyroid storm, also known by its synonyms thyroid crisis, thyrotoxic storm, or 
thyrotoxic crisis, is an extremely rare but life-threatening endocrine emergency. 
It is an acute exaggerated clinical manifestation of thyrotoxic state [1]. It was first 
described by Frank Howard Lahey in 1926 as “the crisis of exophthalmic goiter” [2]. 
Till date, clinicians are puzzled to accurately describe the signs and symptoms of 
thyroid storm as it involves almost all systems of the body. Accurately diagnosing the 
condition is very difficult, and groups around have been working to define a clear 
diagnostic criterion based on universal clinical parameters [3]. Diagnosing the storm 
early is crucial in order to improve the morbidity and mortality associated with it.
2. Epidemiology
2.1 Incidence
Incidence of thyroid storm is not precisely known. Incidence in general popula-
tion was reported as 0.57-0.76 per lac per year in USA and 0.20 per lac per year in 
Japan, whereas incidence in hospitalized patients was 4.8-5.6 per lac per year [4–6]. 
Hospital data suggest that it occurs in 1–2% of patients admitted for thyrotoxicosis 
[5]. It occurs more commonly in women and patients with Graves’ disease [7]. 
Autonomous nodules are the culprit in elderly patients [8].
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2.2 Mortality
Seventy-five percent of patients hospitalized with thyroid storm die [9]. Overall 
mortality rate has been reported to be 10–20% [4, 10–12]. Multiple system dysfunc-
tion is the commonest cause of death, followed by heart failure [13], respiratory 
failure [13], and sepsis [3, 14].
3. Pathophysiology of storm
In order to understand the pathophysiology and rationale of treatment for thyroid 
storm, we need to understand the normal thyroid hormone physiology. Normal thyroid 
function is under control of feedback mechanisms between the hypothalamus, anterior 
pituitary and thyroid gland. “Thyrotropin-releasing hormone” (TRH) stimulates 
anterior pituitary to release “thyroid-stimulating hormone” (TSH), which binds to its 
receptor on thyroid gland and stimulates the synthesis and secretion of thyroid hor-
mone. The thyroid hormone synthesis is a five-step process comprising of: (a) iodide 
trapping; (b) organification—oxidation and iodination; (c) coupling; (d) storage; 
and (e) release. Transport of iodide into the thyroid follicular cell via a sodium-iodide 
symporter is the first step in hormone synthesis, known as “iodide trapping.” Iodide 
is then “oxidized and organified” by thyroid peroxidase enzyme (TPO). Iodination of 
tyrosine residues on thyroglobulin (framework protein for thyroid hormone synthe-
sis) is catalyzed by TPO forming thyroxine (T4) and triiodothyronine (T3). Thyroid 
hormone acts through intranuclear action of T3 with T4 acting more as a “prohormone” 
[15]. Twenty percent of T3 comes directly from thyroid gland and 80% of circulating 
T3 comes from peripheral conversion of T4 to T3. The entire process is controlled by a 
negative feedback loop with peripheral thyroid hormone inhibiting the release and syn-
thesis of TSH and TRH. Majority of the thyroid hormone is protein-bound (>99%) to 
thyroid-binding globulin (TBG), transthyretin, and albumin [16] making a “circulating 
storage pool,” while unbound or free hormone is available for uptake into the tissues.
Peripheral conversion of T4 to T3 is done by the 5′-deiodinases. The deiodinase 
D2 is active in euthyroid state whereas in hyperthyroid state deiodinase D1 is more 
prevalent. The deiodinase D1 is susceptible to inhibition by thionamide and pro-
pylthiouracil (PTU). Glucocorticoids and β-blockers inhibit peripheral conversion 
of T4 to T3. This understanding will help us understand the rationale behind use of 
various classes of drugs in the treatment of thyroid storm.
Exact pathophysiology of thyroid storm is poorly understood. Several hypoth-
eses have been postulated for the storm, which are as follows:
3.1 Acute increase in release of T4 or T3 from thyroid gland
It is the most important mechanism behind thyroid storm [17]. Acute increase in 
T4 or T3 hormones is seen after radioiodine therapy, thyroidectomy, discontinua-
tion of antithyroid drugs, and administration of iodinated contrast agents or iodine 
[18]. Rapid improvements in clinical condition after reduction in T4 or T3 concen-
tration after peritoneal dialysis or plasmapheresis support this theory [19].
3.2  Acute illness causes decrease in protein binding of T4 and T3 in serum 
resulting in increase of free T4 and T3
Acute illnesses lead to decrease in protein binding of T4 and T3 [20], either due 
to decrease in production of transthyretin or due to production of inhibitors of 
T4- and T3-binding protein [21]. They lead to decrease in bound form of T4 and T3, 
3Thyroid Storm: Clinical Manifestation, Pathophysiology, and Treatment
DOI: http://dx.doi.org/10.5772/intechopen.89620
which ultimately leads to relative increase in serum concentration of the hormones, 
which causes storm [22].
3.3 Role of sympathetic nervous system activation
Many symptoms and signs of thyroid storm mimic those of catecholamine 
excess, suggesting the role of sympathetic nervous system activation [23]. Dramatic 
improvement in symptoms following beta blocker administration supports this 
hypothesis [24].
3.4 Augmentation of cellular responses to thyroid hormone
In patients with condition of hypoxemia, ketoacidosis, lactic acidosis, and 
infection, there is augmentation of cellular response to thyroid hormone [25]. There 
is uncoupling of oxidative phosphorylation leading to generation of ATP, which 
results in excess utilization of substrate, increased oxygen consumption, thermo-
genesis, and hyperthermia [26]. Excess heat is dissipated by increased sweating and 
cutaneous vasodilation, the most common symptoms of thyroid storm.
4. Triggers of thyroid storm
The transition from simple thyrotoxicosis to thyrotoxic crisis requires a 
superimposed insult. Any primary cause of hyperthyroidism can escalate into 
thyrotoxic crisis. There are triggers that can induce thyroid storm in patients with 
unrecognized thyrotoxicosis, which includes nonthyroidal surgery, parturition, 
major trauma, infection, or iodine exposure from radiocontrast dyes or amiodarone 
[27]. Common and rare triggers are listed in Table 1. Infection is the most common 
precipitant of thyroid storm in the hospitalized patients [3, 17, 27, 28]. There is no 
identifiable precipitating factor in about 25–43% of patients of storm [29].
5. Clinical features and diagnosis
The diagnosis of thyroid storm is purely clinical, and if suspected, treatment 
should be initiated simultaneously without any delay. Clinical picture comprises 
Common Rare
Infection [6] Vigorous palpation of thyroid gland [30]
Acute medical illness Subacute thyroiditis [31]
Acute psychosis [32] Thyroxine overdosage [33]
Nonthyroidal surgery [18] Aspirin intoxication [34]
Parturition [35] Hydatidiform mole [36]
Trauma [37] OP poisoning [38]
Discontinuation of antithyroid drugs [39] Neurotoxins [40]
After radioactive iodine therapy [41] Cytotoxic chemotherapy [42]
Post-thyroidectomy [43]
After high dose of iodine administration [44]
Iodinated radiographic contrast agents [45]
Table 1. 
Triggers of thyroid storm.
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of an exaggerated feature of hyperthyroidism accompanied by manifestations of 
multiorgan dysfunction, with the presence of an acute precipitating factor [46]. 
Symptoms, signs, and clinical features are listed in Tables 2–4 respectively.
Hyperpyrexia (104–106°F) with diaphoresis is the key presenting feature. 
High fever induces profuse sweating and leads to insensible fluid losses, which 
is a differentiating feature between thyroid storm and thyrotoxicosis [1]. 
Cardiovascular manifestations include palpitations, tachycardia, exercise intoler-
ance, dyspnea on exertion, widened pulse pressure, myocardial ischemia, and 
atrial fibrillation. Heart rate > 140/min is out of proportion to the underlying 
illness [47]. The increased cardiac output and tachyarrhythmia may progress 
to cardiogenic shock [48, 49]. The central nervous system (CNS) manifesta-
tions include agitation, delirium, confusion, stupor, obtundation, and coma. 
CNS involvement is a poor prognostic factor for mortality [3]. Gastrointestinal 
(GI) symptoms include nausea, vomiting, diarrhea, abdominal pain, intestinal 
obstruction, and acute hepatic failure [29]. Vomiting and diarrhea add to signifi-
cant fluid loss. Liver dysfunction and hepatomegaly are due to hepatic congestion 
and hypoperfusion, or directly due to hyperthyroidism [17]. Jaundice is a poor 
prognostic indicator [50]. Unusual presentations include acute abdomen, status 
epilepticus, rhabdomyolysis, hypoglycemia, lactic acidosis, and disseminated 
intravascular coagulation [51–54].
Various clinical entities that mimic thyroid storm exist, which confounds the 
existent diagnostic dilemma, namely, peritonitis [55], sepsis/septic shock [56], heat 
stroke [57], malignant hyperthermia [58], acute pulmonary edema [59], neuroleptic 
malignant syndrome [60], and serotonin syndrome [61]. The mimics of thyroid 
storm are listed in Table 5.
Hyperactivity, irritability, dysphoria
Heat intolerance and sweating
Palpitations
Fatigue and weakness
Weight loss with increased appetite
Diarrhea
Polyuria
Oligomenorrhea, loss of libido
Table 2. 
Symptoms of thyroid storm.
Tachycardia, atrial fibrillation
Tremor
Goiter
Warm, moist skin
Muscle weakness, proximal myopathy
Lid retraction or lag
Gynecomastia
Signs of ophthalmopathy and dermopathy specific for Grave’s disease
Table 3. 
Signs of thyroid storm.
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Abrupt onset
Fever—high grade
Progressively increasing to lethal levels within 24–48 h
Warm skin, flushing, profuse diaphoresis
Goiter and exophthalmos ±
Tachycardia >140 beats/min, atrial fibrillation
Agitation, delirium, psychosis, coma
Diarrhea, nausea, vomiting, pain abdomen, unexplained jaundice
Table 4. 
Clinical features of thyroid storm.
Peritonitis
Sepsis/septic shock
Heat stroke
Malignant hyperthermia
Acute pulmonary edema
Neuroleptic malignant syndrome
Serotonin syndrome
Peritonitis
Table 5. 
Mimics of thyroid storm.
Figure 1. 
Burch and Wartofsky’s diagnostic criteria for thyroid storm [28].
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Burch and Wartofsky [28] assigned a numerical score to each of the different signs 
and symptoms of thyroid storm to establish a diagnostic criterion based on the total 
score calculated as shown in Figure 1. Japan Thyroid Association surveyed the inci-
dence of thyroid storm in Japan and formulated population-specific diagnostic criteria 
based on the presence of the classic organ system manifestations as shown in Table 6.
Both Burch and Wartofsky score (BWS) and the Japan Thyroid Association 
(JTA) guidelines are acceptable. However, in one study, BWS ≥45 was reported to 
Prerequisite for diagnosis
Presence of thyrotoxicosis with elevated levels of free triiodothyronine (FT3) or free thyroxine (FT4)
Symptoms
1. Central nervous system (CNS) manifestations: restlessness, delirium, mental aberration/psychosis, 
somnolence/lethargy, coma (≥1 on the Japan Coma Scale or ≤14 on the Glasgow Coma Scale)
2. Fever: ≥ 38°C
3. Tachycardia: ≥130 beats per minute or heart rate ≥ 130 in atrial fibrillation
4. Congestive heart failure (CHF): pulmonary edema, wet crackles over more than half of the lung field, 
cardiogenic shock, or Class IV by the New York Heart Association or ≥Class III in the Killip classification
5. Gastrointestinal (GI)/hepatic manifestations: nausea, vomiting, diarrhea, or a total bilirubin 
level ≥ 3.0 mg/dL
Diagnosis
Grade of thyroid storm (TS) Combinations of 
features
Requirements for 
diagnosis
TS1 First 
combination
Thyrotoxicosis and 
at least one CNS 
manifestation and fever, 
tachycardia, CHF, or GI/ 
hepatic manifestations
TS1 Alternate 
combination
Thyrotoxicosis and at 
least three combinations 
of fever, tachycardia, 
CHF, or GI/ hepatic 
manifestations
TS2 First 
combination
Thyrotoxicosis and a 
combination of two of 
the following: fever, 
tachycardia, CHF, or GI/
hepatic manifestations
TS2 Alternate 
combination
Patients who met the 
diagnosis of TS1 except 
that serum FT3 or FT4 
level are not available
Exclusion and provisions
Cases are excluded when clear cut underlying pathology is present for the following symptoms: fever 
(e.g., pneumonia and malignant hyperthermia), impaired consciousness (e.g., psychiatric disorders and 
cerebrovascular disease), heart failure (e.g., acute myocardial infarction), and liver disorders (e.g., viral 
hepatitis and acute liver failure). Therefore, it is difficult to determine whether the symptom is caused by TS 
or is simply a manifestation of an underlying disease; the symptom should be regarded as being due to a TS 
that is caused by these precipitating factors. Clinical judgment in this matter is required.
TS1, “Definite” TS; TS2, “Suspected” TS.
Adapted from: Akamizu et al. [3].
Table 6. 
The diagnostic criteria for thyroid storm (TS) of the Japan Thyroid Association.
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be more sensitive than JTA guidelines in detecting patients with storm [62, 63]. It 
is recommended to use both criteria to increase the accuracy of the diagnosis of 
thyroid storm [44, 63].
Although diagnosis of thyroid storm is clinical, laboratory values aid in the 
diagnosis and treatment. A complete workup including estimation of TSH, free T4, 
and free T3 should be done in the intensive care unit (ICU) setting. Leukocytosis 
indicates infection (commonest factor for storm). Elevated blood urea nitrogen [3] 
and liver function abnormalities with elevation in the transaminases and hyperbili-
rubinemia indicate irreversible abnormalities. Hypercalcemia may be found due 
to the high bone resorption that accompanies hyperthyroidism and can exacerbate 
dehydration. Hyperglycemia is due to a combination of increased catecholamine 
inhibition of insulin release and increased gluconeogenesis [64].
6. Management
The treatment of thyroid storm should be initiated as soon as the diagnosis is 
suspected. Patients should be triaged to an intensive care setting for close monitor-
ing and aggressive treatment. A multidisciplinary team approach is important in 
order to successfully offer the patient all possible therapeutic options. Immediate 
goals of thyroid-specific therapy should be targeted to decrease thyroid hormone 
synthesis and release, decrease peripheral action of thyroid hormone, and treat the 
precipitating cause.
6.1 Inhibiting new thyroid hormone synthesis
The first-line therapy in treating thyroid storm consists of inhibiting new 
thyroid hormone production. This approach most commonly utilizes thionamides 
which includes thiouracils (PTU) and imidazoles (methimazole and carbimazole). 
They inhibit thyroid peroxidase (TPO), thereby inhibiting formation of T3 and T4 
from thyroglobulin [65]. Both methimazole and PTU are used but PTU is favored 
during thyroid storm due to its additional benefit over carbimazole and methima-
zole, namely rapid onset of action and inhibition of peripheral conversion of T4 
to T3 mediated by peripheral deiodinase. In addition, PTU can be safely used in 
pregnancy.
The dose of PTU is 600–1500 mg/day in divided doses every 4–6 h [27, 28, 66] 
with a loading dose of 600 mg. Dose of methimazole is 80–120 mg daily in divided 
doses every 4–6 h [27, 28, 66]. The American Association of Clinical Endocrinologist/
American Thyroid Association guidelines recommend 500–1000 mg loading dose 
of PTU followed by 250 mg every 4 h and 60–80 mg/day of methimazole in divided 
doses [67]. Routes of administration include intravenous, enteral, and per rectal 
as suppository or retention enema. PTU is relatively insoluble at physiologic pH, 
therefore its intravenous preparation and administration are difficult. Intravenous 
methimazole can be prepared easily by dissolving methimazole powder in normal 
saline [68].
Nonradioactive iodine also decreases new thyroid hormone synthesis. It is due 
to the inhibition of organic binding of iodide to thyroglobulin as plasma iodide 
levels reach a critical threshold, a phenomenon known as the Wolff-Chaikoff effect. 
The effect is transient, lasting for about 50 h, as the thyroid eventually escapes/
adapts to prolonged iodide excess [69]. Inorganic iodine may be given orally as a 
saturated solution of potassium iodide (SSKI) by administering five drops (0.25 mL 
or 250 mg) every 6 h or as Lugol’s solution (eight drops given every 6 h) [28, 67]. 
Routes can be enteral, rectal, or intravenous. SSKI is prepared for rectal dosing by 
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mixing 1 g of iodide in 60 mL of water and administering 2 g/day in divided doses 
[70]. Lugol’s solution can be given rectally in doses of 4 mL (80 drops) per day [71]. 
Iodine should be given at least 30 min after administering thionamides to avoid the 
iodine serving as a substrate for new thyroid hormone production and worsening 
the hyperthyroidism. Thionamides must be continued during therapy with iodine 
to avoid organification of iodine and increased thyroid hormone production. 
Iodine administration delays definitive treatment of patients’ hyperthyroidism with 
radioactive iodine [27, 28]. Therefore, iodine should be used only when the end goal 
is thyroidectomy.
Lithium hampers T4 and T3 synthesis by inhibiting the coupling of iodotyrosine 
residues. When iodine administration is not possible (secondary to iodine induced 
anaphylaxis) or desired, lithium may be substituted. It is administered at doses of 
300 mg every 6–8 h with monitoring of serum levels.
6.2 Inhibiting thyroid hormone release
The next line of treatment is inhibiting the release of preformed hormone. 
Iodine administration, additionally, blocks the release of preformed hormone by 
inhibiting the release of iodothyronines (T3 and T4) from thyroglobulin [28, 72]. 
This effect of iodine has a faster onset than PTU, which blocks synthesis in a thyroid 
gland that has a large store of already formed hormone [73]. The combination 
therapy of thionamides and iodine decrease serum T4 levels to normal range in 
4–5 days [74].
6.3 Inhibiting the peripheral effect of thyroid hormone
Both α- and β-adrenergic stimulation are enhanced in thyroid storm. Thus, 
adrenergic blockade is an integral part of the treatment. β-Blockers have been 
used in treatment of both uncomplicated and complicated hyperthyroidism 
[75]. Propranolol is the most commonly used β-blocker due to its nonselective 
β-adrenergic antagonism and its ability to block the peripheral conversion of T4 to 
T3. The recommended dose is 60–120 mg orally every 6 h [64]. For a more rapid 
effect, intravenous propranolol or a shorter acting β-blocker such as esmolol can be 
used. The dose of intravenous propranolol is 0.5–1.0 mg slow infusion for an initial 
dose and then 1–2 mg at 15-min intervals while monitoring the heart rate carefully. 
Esmolol is given as an initial bolus of 0.25–0.5 mg/kg followed by a continuous 
infusion rate of 0.05–0.1 mg/kg per minute [73].
6.4 Inhibiting enterohepatic circulation of thyroid hormone
Enterohepatic circulation of thyroid hormone is targeted for severe and 
refractory thyroid storm. Thyroid hormone is metabolized in the liver where it is 
conjugated to glucuronides and sulfates. Conjugated products are excreted into the 
intestine through bile, where free hormones are released, reabsorbed, and circu-
lated. This is enterohepatic circulation of thyroid hormone. Cholestyramine binds 
the conjugation products and promotes their excretion, and can be used to decrease 
thyroid hormone levels. The recommended dose is 1–4 g twice a day [76–78].
6.5 Other therapies
The oral iodinated contrast agents are inhibitors of both deiodinases D1 and 
D2 and help in lowering T3 levels. Additionally, they inhibit new thyroid hormone 
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synthesis and release of preformed hormones from the gland. They are given as 2 g 
loading dose followed by 1 g daily [74, 79]. Lower doses are given for preoperative 
preparation for thyroid surgery [80, 81] and as an adjunct to thionamides in treat-
ment of Graves’ disease [82].
6.6 Supportive and resuscitative measures
Resuscitative measures should be initiated immediately in an ICU setting. 
Urgent addressal of systemic decompensation requires correction of hyperthermia, 
dehydration, congestive heart failure, dysrhythmia, and prevention of adrenal crisis 
[73]. Hyperthermia should be controlled with peripheral cooling and antipyretics. 
Acetaminophen is preferred over salicylates as salicylates increase free hormone 
levels by decreasing binding to T4-binding globulin, thereby exacerbating thyroid 
storm [83]. The peripheral cooling should be done with ice packs, cooling blankets, 
or alcohol sponges. Fluid loss due to hyperpyrexia, diarrhea, and vomiting should 
be corrected immediately.
The hypothalamo-pituitary-adrenal axis is impaired in thyrotoxicosis with 
a decrease in adrenal reserve. Despite increased production of cortisol by the 
adrenal gland to compensate for accelerated glucocorticosteroid metabolism in 
hyperthyroid states, a subnormal response of the adrenal glands to adrenocortico-
stimulating hormone occurs. Corticosteroids are therefore used as adjunct therapy 
in thyroid storm to prevent adrenal insufficiency. It also helps in decreasing the 
peripheral conversion of T4 to T3 [84]. A loading dose of 300 mg of hydrocortisone 
intravenously followed by 100 mg every 8 h is recommended [67].
The treatment of thyroid storm is not complete and effective until correctable 
precipitating factors are addressed (Table 1). Any focus of infection should be 
thoroughly investigated and proper antibiotics should be started based on sensitiv-
ity. In addition, any metabolic abnormalities, such as diabetic ketoacidosis, stroke, 
or pulmonary emboli, should be treated as per standard protocols.
6.7 Therapeutic plasma exchange
In refractory cases of thyrotoxic crisis with no clinical improvement alterna-
tive measures to clear thyroid hormone from the circulation should be instituted. 
Therapeutic plasma exchange (TPE) is effective in rapidly reducing thyroid 
hormone levels [85]. The patient’s plasma is extracted from the components of 
blood, and replaced with albumin or fresh frozen plasma [85, 86]. TBG with bound 
thyroid hormone is removed from circulation, and the colloid replacement (usually 
albumin) provides unsaturated binding sites for circulating free thyroid hormone. 
Various techniques of exchange transfusion have evolved since its first description 
in 1970 by Ashkar et al. [87]. Plasma exchange, single pass albumin dialysis, and 
charcoal hemoperfusion have all demonstrated a reduction in free T3 and free T4 
levels [85].
TPE is an option when clinical deterioration in thyroid storm occurs despite 
the use of first- and second-line therapies. Muller et al. suggested early initiation 
of TPE with the following indications: severe symptoms (cardio-thyrotoxicosis, 
neurologic manifestations, and severe myopathy); rapid clinical deterioration; 
contraindications to other therapies; and failure of conventional therapeutics [88]. 
The American Society for Apheresis (ASFA) recommends that TPE be performed 
at a frequency of daily to every 2–3 days until clinical improvement is noted. 
Complications of TPE are seen in 5% of patients and include hypotension, hemoly-
sis, allergic reactions, coagulopathy, vascular injury, and infection [86, 88, 89].
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6.8 Surgical management
Achieving a euthyroid state is first and foremost requisite prior to surgical man-
agement using the above-mentioned medical treatment strategies [27]. However, 
there is a subset of patients who fail medical management despite all of the most 
aggressive treatment modalities. This occurs more commonly in iodine-deficient 
areas, where thyroid storm is mostly related to iodine contamination in patients 
with thyroid autonomy. These patients are particularly resistant to even high-dose 
thionamides or iodine therapy because of the large intrathyroidal iodine pool [90]. 
The broad indications of surgery have been listed in Table 7.
All measures should be employed to stabilize the patient prior to considering emer-
gent surgical management. Surgical team should be involved early (within 12–72 h) 
if the patient is not responding to medical therapy. The surgical options involve a 
subtotal or near-total thyroidectomy [73]. The surgery produces rapid resolution of 
the hyperthyroidism as very little thyroid tissue remains. This allows cessation of the 
thionamides soon after the surgery. Corticosteroid and β-blocker should be continued 
perioperatively and slowly weaned off over the ensuing weeks [27].
6.9 Newer agents
Biological agent Rituximab (anti-CD20 monoclonal antibody which depletes 
B lymphocytes) and various other emerging therapies have shown promise in the 
treatment of Graves’ ophthalmopathy, but the role of these agents in the manage-
ment of the thyrotoxic state is less clear [17, 91–93].
7. Conclusion
Thyroid storm is an endocrine emergency that is associated with high morbidity 
and mortality if not promptly recognized and treated. Multidisciplinary treatment 
Absolute indication Relative indication
Failed medical therapy Symptomatic goiter
Severe reaction to antithyroid drugs Pregnancy
Not a candidate for radio ablation therapy Severe Grave’s ophthalmopathy
Persistent thyrotoxicosis despite maximum antithyroid drug/radio 
ablation therapy
Underlying thyroid carcinoma
Suspicious/malignant nodules on FNAC
Refractory thyroiditis Amiodarone 
related
Toxic adenoma
Table 7. 
Indications of surgery.
Block synthesis (anti thyroid drugs)
Block release (iodine)
Block T4 to T3 conversion (high dose PTU, propranolol, corticosteroid)
Beta blocker
Block enterohepatic circulation (cholestyramine)
Table 8. 
Five B’s of thyroid storm.
11
Thyroid Storm: Clinical Manifestation, Pathophysiology, and Treatment
DOI: http://dx.doi.org/10.5772/intechopen.89620
Author details
Rahul Pandey*, Sanjeev Kumar and Narendra Kotwal
Armed Forces Clinic, New Delhi, India
*Address all correspondence to: rahuladviksimpy@gmail.com
in an intensive care setting is usually needed. Treatment involves addressing all 
steps of thyroid hormone synthesis, release, and action, in a well-defined order, 
while providing supportive care. Remember five B’s in thyroid storm as listed in 
Table 8. Treating precipitating factors is an integral part of the management.
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